Heart Inflammation Declining In The United States

November 09, 1998

Cases of life-threatening heart muscle inflammation are declining in the United States, mirroring a decline in enteroviral infections that often lead to the inflammation, according to a Johns Hopkins study.

"We have seen a decline in the number of cases of inflammation, known as viral myocarditis, at The Johns Hopkins Hospital since the mid-1980s, but there may be a resurgence at some point, as the cases tend to follow epidemic as well as pandemic patterns," says Robert E. McCarthy III, M.D., lead author of the study and an assistant professor of medicine at Hopkins.

Results of the study will be presented at 1:30 p.m., Nov. 9 at the American Heart Association's 71st annual Scientific Sessions in Dallas.

Researchers took biopsies of the hearts of 1,757 patients who came to Hopkins between 1985 and 1996 with new-onset heart failure or abnormal heart rhythms. Myocarditis was present in 157 patients (9 percent) who had no other disease associated with heart inflammation.

The number and proportion of patients with primary myocarditis decreased significantly during the time period, from 22 (28 percent) in 1985 to three (2 percent) in 1996. Furthermore, since 1991, myocarditis was present in less than 5 percent of patients biopsied each year. This correlates with the annual reduction of enterovirus cases reported by the federal Centers for Disease Control and Prevention since 1993.

"Knowing that cases of myocarditis could follow an epidemic, continued efforts to improve the diagnosis and treatment of this disorder are warranted," McCarthy says.

The study's other authors are Ralph H. Hruban, M.D.; Joshua M. Hare, M.D.; Edward K. Kasper, M.D.; and Kenneth L. Baughman, M.D.
Johns Hopkins Medical Institutions' news releases are available on a PRE-EMBARGOED basis on EurekAlert at http://www.eurekalert.org, Newswise at http://www.newswise.com and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkins@jhmi.edu.

On a POST-EMBARGOED basis find them at http://hopkins.med.jhu.edu, Quadnet at http://www.quad-net.com and ScienceDaily at http://www.sciencedaily.com.

Media Contact: Karen Infeld
410-446-3294 (AHA conference, cellular phone)
214-742-5678 (Hampton Inn West End)
410-955-1534 (after 11/11/98)

Johns Hopkins Medicine

Related Inflammation Articles from Brightsurf:

3D printed stents that treat inflammation
POSTECH Professor Dong-Woo Cho's research team develops bioink-loaded esophageal stents for treating radiation esophagitis.

New cause of inflammation in people with HIV identified
A new study led by researchers at Boston Medical Center examined what factors could be contributing to this inflammation, and they identified the inability to control HIV RNA production from existing HIV DNA as a potential key driver of inflammation.

Maltreatment tied to higher inflammation in girls
New research by a University of Georgia scientist reveals that girls who are maltreated show higher levels of inflammation at an early age than boys who are maltreated or children who have not experienced abuse.

A protein that controls inflammation
A study by the research team of Prof. Geert van Loo (VIB-UGent Center for Inflammation Research) has unraveled a critical molecular mechanism behind autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis.

Inflammation in the brain linked to several forms of dementia
Inflammation in the brain may be more widely implicated in dementias than was previously thought, suggests new research from the University of Cambridge.

Social isolation could cause physical inflammation
Social isolation could be associated with increased inflammation in the body new research from the University of Surrey and Brunel University London has found.

Hydrogels control inflammation to help healing
Researchers test a sampling of synthetic, biocompatible hydrogels to see how tuning them influences the body's inflammatory response.

Why beta-blockers cause skin inflammation
Beta-blockers are often used to treat high blood pressure and other cardiovascular diseases.

The 'inflammation' of opioid use
New research correlates inflammation in the brain and gut to negative emotional state during opioid withdrawal.

Using a common anticonvulsant to counteract inflammation
The interaction between a chromosomal protein called HMGB1 and a cellular receptor called RAGE is known to trigger inflammation.

Read More: Inflammation News and Inflammation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.